# US 2026/0226383 A1 · Digital molecular fingerprinting on organ on a chip systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0226383 A1
- Document ID: US20260226383A1
- Status: Published application
- Kind: A1
- Application number: 19/142,420
- Filed: 2023-12-13
- Published: 2026-08-06
- Earliest claimed: 2022-12-23
- Assignees: University of Rochester; The Regents of the University of Michigan
- Applicants: University of Rochester; The Regents of the University of Michigan
- Inventors: James L. MCGRATH; Benjamin H. SINGER; Andrew STEPHENS; Yujing SONG; Katsuo KURABAYASHI; Shiuan-Haur SU
- Web page: https://patentgrep.com/patent/US20260226383A1

## CPC

- C12M 23/16: {Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093)}
- C12M 3/06: with filtration, ultrafiltration, inverse osmosis or dialysis means
- C12M 29/04: {Filters; Permeable or porous membranes or plates, e.g. dialysis}
- G01N 33/5058: {Neurological cells}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- C12M 1/12: with sterilisation, filtration or dialysis means
- C12M 1/34: Measuring or testing with condition measuring or sensing means, e.g. colony counters
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present disclosure relates to systems, devices, and methods for using a first component (e.g., having a top reservoir and bottom reservoir that are fluidically connected through, and only through, a nanoporous membrane) that is able to be mated with a second component that comprises a plurality of microwells. Stimulating agents and/or candidate therapeutics may be added to the top reservoir such that cells (e.g., endothelial cells) in the top reservoir release one or more analytes that pass through the nanoporous membrane into the bottom reservoir (which may contain cells such as neurons) and into the microwells where they are captured and then detected.

## Claims

### Claim 1

A system comprising:
a) a first component comprising:
i) a housing block having a top surface, a bottom surface, and top reservoir recessed in said top surface,
wherein said top reservoir comprises: one or more side walls and a bottom wall in proximity to said bottom surface of said housing block and having a reservoir hole therein,
ii) a membrane chip comprising a membrane housing and a nanoporous membrane, wherein said membrane chip is configured to sit on or near said bottom wall of said top reservoir such that said nanoporous membrane protrudes through said reservoir hole out past said bottom surface of said housing block, and
iii) optionally an adhesive layer that is sized to stick to said bottom surface of said housing block, and
iv) a film layer with a top surface and a bottom surface, wherein said film layer has an opening therein, wherein said opening comprises a film perimeter wall that forms a bottom reservoir when: A) said top surface of said film layer is mated with said bottom surface of said housing block, optionally via said adhesive layer, and B) said bottom surface of said film layer is mated with a second component, optionally via pressure.

### Claim 2 (depends on 1)

The system of claim 1, wherein said top reservoir and said bottom reservoir are fluidically connected through, and only through, said nanoporous membrane when said housing block, membrane chip, and said film are assembled together, optionally with said adhesive layer.

### Claim 3 (depends on 2)

The system of claim 2, wherein said housing block, membrane chip, and said film are assembled together, optionally via said adhesive layer.

### Claim 4 (depends on 1)

The system of claim 1, wherein said adhesive layer is present in said system and comprises two-sided film adhesive.

### Claim 5 (depends on 1)

The system of claim 1, further comprising said second component.

### Claim 6 (depends on 5)

The system of claim 5, wherein said second component comprises a microwell chip, wherein said microwell chip comprises a surface with a plurality of microwells therein.

### Claim 7 (depends on 6)

The system of claim 6, wherein said plurality of microwells are in fluidic communication with said bottom reservoir when said first component is assembled and mated with said second component.

### Claim 8 (depends on 6)

The system of claim 6, wherein said microwell chip comprises glass.

### Claim 9 (depends on 6)

The system of claim 6, wherein said plurality of microwells comprises at least 1000 microwells.

### Claim 10 (depends on 6)

The system of claim 6, wherein said plurality of microwells are present in at least two or at least three distinct arrays.

### Claim 11 (depends on 6)

The system of claim 6, wherein each of said plurality of microwells comprises an analyte binding agent.

### Claim 12 (depends on 11)

The system of claim 11, wherein said analyte comprises a cytokine or chemokine.

### Claim 13 (depends on 10)

The system of claim 10, wherein each of said at least two or at least three distinct arrays comprises a different analyte binding agent configured to bind a different analyte.

### Claim 14 (depends on 1)

The system of claim 1, wherein said top reservoir comprises a first suspension of cells, and optionally a stimulating agent or candidate therapeutic, wherein said stimulating agent is optionally LPS, and wherein said candidate therapeutic is optionally a small molecule, antibody or antigen binding fragment thereof, a nanoparticle, or a liposome.

### Claim 15 (depends on 14)

The system of claim 14, wherein said first suspension of cells comprises endothelial cells, which has optionally formed a layer on said nanoporous membrane.

### Claim 16 (depends on 15)

The system of claim 15, wherein said endothelial cells comprise brain microvascular endothelial cells.

### Claim 17 (depends on 5)

The system of claim 5, wherein said first component is assembled and mated with said second component such that said bottom reservoir is formed, and wherein said bottom reservoir comprises a second suspension of cells.

### Claim 18 (depends on 17)

The system of claim 17, wherein said second suspension of cells comprises neurological cells or brain cells.

### Claim 19 (depends on 18)

The system of claim 18, wherein said neurological cells comprise neurons.

### Claim 20

A device comprising: a first component which comprises:
a) a housing block having a top surface, a bottom surface, and top reservoir recessed in said top surface, wherein said top reservoir comprises: one or more side walls and a bottom wall in proximity to said bottom surface of said housing block and having a reservoir hole therein,
b) a membrane chip comprising a membrane housing and a nanoporous membrane, wherein said membrane chip is seated on or near said bottom wall of said top reservoir such that said nanoporous membrane protrudes through said reservoir hole out past said bottom surface of said housing block, and
c) optionally an adhesive layer that is stuck to said bottom surface of said housing block, and
d) a film layer with a top surface and a bottom surface, wherein said film layer has an opening therein, wherein said opening comprises a film perimeter wall that forms a bottom reservoir when: A) said top surface of said film layer is mated with said bottom surface of said housing block, optionally via said adhesive layer, and B) said bottom surface of said film layer is mated with a second component, optionally via pressure.

### Claim 21 (depends on 20)

The device of claim 20, wherein said top reservoir and said bottom reservoir are fluidically connected through, and only through, said nanoporous membrane.

### Claim 22 (depends on 20)

The device of claim 20, wherein said adhesive layer is present and comprises two-sided film adhesive.

### Claim 23 (depends on 20)

A method comprising:
a) sealing said film layer of said first component of said device of claim 20 against a first location on a second component such that said bottom reservoir is formed,
wherein said second component comprises a microwell chip, wherein said first location on said microwell chip comprises a surface with a first plurality of microwells therein,
wherein each of said first plurality of microwells comprises analyte binding agents, and
wherein said sealing is such that said plurality of microwells are in fluidic communication with said bottom reservoir,
b) adding a first cell suspension comprising a plurality of cells to said top reservoir of said first component,
c) adding a stimulating agent and/or candidate therapeutic to said top reservoir of said first component under conditions such that at least some of said plurality of cells secrete one or more analytes that: i) pass through said nanoporous membrane, ii) flow into said bottom reservoir, and iii) flow into at least a portion of said first plurality of microwells; and
d) detecting any bound analytes in said a least a portion of said first plurality of microwells at a first time.

### Claim 24 (depends on 23)

The method of claim 23, wherein said detecting is performed by optical detection of an added label.

### Claim 25 (depends on 23)

The method of claim 23, further comprising: e) moving said first component to a second location on said second component such that said bottom reservoir remains formed, wherein said second location on said microwell chip comprises a surface with a second plurality of microwells therein, wherein said second plurality of microwells comprises analyte binding agents.

### Claim 26 (depends on 25)

The method of claim 25, wherein said moving comprises sliding said first component across said second component from said first location to said second location.

### Claim 27 (depends on 23)

The method of claim 23, wherein said top reservoir and said bottom reservoir are fluidically connected through, and only through, said nanoporous membrane.

### Claim 28 (depends on 23)

The method of claim 23, wherein said adhesive layer is present in said system and comprises two-sided film adhesive.

### Claim 29 (depends on 23)

The method of claim 23, wherein said microwell chip comprises glass.

### Claim 30 (depends on 23)

The method of claim 23, wherein said first plurality of microwells comprises at least 1000 microwells.

### Claim 31 (depends on 23)

The method of claim 23, wherein said first plurality of microwells are present in at least two or at least three distinct arrays.

### Claim 32 (depends on 23)

The method of claim 23, wherein said analyte comprises a cytokine or chemokine.

### Claim 33 (depends on 23)

The method of claim 23, wherein said first cell suspension comprises endothelial cells, which have optionally formed a layer on said nanoporous membrane.

### Claim 34 (depends on 33)

The method of claim 33, wherein said endothelial cells comprise brain microvascular endothelial cells.

### Claim 35 (depends on 23)

The method of claim 23, wherein said bottom reservoir comprises a second suspension of cells comprises neurological cells or brain cells.

### Claim 36 (depends on 35)

The method of claim 35, wherein said neurological cells comprise neurons.

### Claim 37 (depends on 20)

A method comprising;
a) adding a first cell suspension comprising a plurality of cells to said top reservoir of said first component of said device of claim 20,
wherein said first component is sealed against a second component such that said bottom reservoir is formed,
wherein said second component comprises a microwell chip, wherein said first location on said microwell chip comprises a surface with a first plurality of microwells therein,
wherein each of said first plurality of microwells comprises analyte binding agents, and
wherein said sealing is such that said plurality of microwells are in fluidic communication with said bottom reservoir,
b) adding a stimulating agent and/or candidate therapeutic to said top reservoir of said first component under conditions such that at least some of said plurality of cells secrete one or more analytes that: i) pass through said nanoporous membrane, ii) flow into said bottom reservoir, and iii) flow into at least a portion of said first plurality of microwells; and
c) detecting any bound analytes in said at least a portion of said first plurality of microwells at a first time.
